Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 $ 632,602   $ 306 $ (67,858) $ 761,128 $ (994) $ (58,882)   $ (1,098)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     200,326            
Exercise of stock options 3,163   $ 1   3,162        
Issuance of common stock - vesting of restricted stock units (in shares)     479,479            
Issuance of common stock - vesting of restricted stock units 2   $ 2            
Acquisition of business (in shares)     15,755            
Acquisition of business 772       772        
Stock-based compensation expense 12,864       12,864        
Shares witheld to satisfy tax withholdings (in shares)       (160,456)          
Shares withheld to satisfy tax withholdings (9,819)     $ (9,819)          
Foreign currency translation gain (loss), net of taxes 222         222      
Net income (loss) (18,268)           (18,185)   (83)
Balance at period end (in shares) at Mar. 31, 2019     61,934,458 13,277,554          
Balance, at period end at Mar. 31, 2019 621,538   $ 309 $ (77,677) 777,926 (772) (77,067)   (1,181)
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 632,602   $ 306 $ (67,858) 761,128 (994) (58,882)   (1,098)
Increase (decrease) in shareholders' equity                  
Transfer of non-controlling units 0                
Foreign currency translation gain (loss), net of taxes (1,124)                
Net income (loss) (20,619)                
Balance at period end (in shares) at Sep. 30, 2019     65,883,873 13,430,052          
Balance, at period end at Sep. 30, 2019 860,918   $ 329 $ (87,555) 1,030,861 (2,118) (79,254)   (1,345)
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 632,602   $ 306 $ (67,858) 761,128 (994) (58,882)   (1,098)
Balance at period end (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period end at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) $ (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Balance at period start (in shares) at Mar. 31, 2019     61,934,458 13,277,554          
Balance, at period start at Mar. 31, 2019 $ 621,538   $ 309 $ (77,677) 777,926 (772) (77,067)   (1,181)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     114,109            
Exercise of stock options 1,751   $ 1   1,750        
Issuance of common stock - vesting of restricted stock units (in shares)     182,390            
Issuance of common stock - vesting of restricted stock units 1   $ 1            
Acquisition of business (in shares)     3,184,713            
Acquisition of business 222,484   $ 16   222,468        
Stock-based compensation expense 13,434       13,434        
Shares witheld to satisfy tax withholdings (in shares)       (67,960)          
Shares withheld to satisfy tax withholdings (6,143)     $ (6,143)          
Foreign currency translation gain (loss), net of taxes 112         112      
Net income (loss) 613           893   (280)
Balance at period end (in shares) at Jun. 30, 2019     65,415,670 13,345,514          
Balance, at period end at Jun. 30, 2019 853,790   $ 327 $ (83,820) 1,015,578 (660) (76,174)   (1,461)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     225,414            
Exercise of stock options 2,115   $ 1   2,114        
Issuance of common stock - vesting of restricted stock units (in shares)     242,789            
Issuance of common stock - vesting of restricted stock units 1   $ 1            
Stock-based compensation expense 13,169       13,169        
Shares witheld to satisfy tax withholdings (in shares)       (84,538)          
Shares withheld to satisfy tax withholdings (3,735)     $ (3,735)          
Foreign currency translation gain (loss), net of taxes (1,458)         (1,458)      
Net income (loss) (2,964)           (3,080)   116
Balance at period end (in shares) at Sep. 30, 2019     65,883,873 13,430,052          
Balance, at period end at Sep. 30, 2019 860,918   $ 329 $ (87,555) 1,030,861 (2,118) (79,254)   (1,345)
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period start at Dec. 31, 2019 867,576 (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     357,974            
Exercise of stock options 3,408   $ 2   3,406        
Issuance of common stock - vesting of restricted stock units (in shares)     398,881            
Issuance of common stock - vesting of restricted stock units 2   $ 2            
Stock-based compensation expense 13,765       13,765        
Shares witheld to satisfy tax withholdings (in shares)       (130,164)          
Shares withheld to satisfy tax withholdings (9,199)     $ (9,199)          
Foreign currency translation gain (loss), net of taxes (3,024)         (3,024)      
Net income (loss) (7,190)           (7,336)   146
Balance at period end (in shares) at Mar. 31, 2020     67,077,561 13,609,164          
Balance, at period end at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312 (4,773) (84,141)   (1,372)
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period start at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) $ (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares) 587,121                
Transfer of non-controlling units $ 771                
Foreign currency translation gain (loss), net of taxes 290                
Net income (loss) (10,338)                
Balance at period end (in shares) at Sep. 30, 2020     67,584,956 13,700,057          
Balance, at period end at Sep. 30, 2020 $ 953,367   $ 337 $ (107,248) 1,150,198 (1,459) (87,155)   (1,306)
Increase (decrease) in shareholders' equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Balance at period start (in shares) at Mar. 31, 2020     67,077,561 13,609,164          
Balance, at period start at Mar. 31, 2020 $ 864,197   $ 335 $ (100,164) 1,054,312 (4,773) (84,141)   (1,372)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     184,475            
Exercise of stock options 3,275   $ 1   3,274        
Issuance of common stock - vesting of restricted stock units (in shares)     134,207            
Issuance of common stock - vesting of restricted stock units 1   $ 1            
Stock-based compensation expense 13,006       13,006        
Shares witheld to satisfy tax withholdings (in shares)       (43,697)          
Shares withheld to satisfy tax withholdings (3,617)     $ (3,617)          
Transfer of non-controlling units 771       910       (139)
Foreign currency translation gain (loss), net of taxes 1,575         1,575      
Net income (loss) (5,471)           (4,924)   (547)
Balance at period end (in shares) at Jun. 30, 2020     67,396,243 13,652,861          
Balance, at period end at Jun. 30, 2020 873,737   $ 337 $ (103,781) 1,071,502 (3,198) (89,065)   (2,058)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     44,672            
Exercise of stock options 1,370       1,370        
Issuance of common stock - vesting of restricted stock units (in shares)     144,041            
Stock-based compensation expense 15,729       15,729        
Shares witheld to satisfy tax withholdings (in shares)       (47,196)          
Shares withheld to satisfy tax withholdings (3,467)     $ (3,467)          
Capital contribution - non-controlling interest         (339)       339
Issuance of Convertible Notes due 2025, net of offering costs and taxes of $8,617 61,936       61,936        
Foreign currency translation gain (loss), net of taxes 1,739         1,739      
Net income (loss) 2,323           1,910   413
Balance at period end (in shares) at Sep. 30, 2020     67,584,956 13,700,057          
Balance, at period end at Sep. 30, 2020 $ 953,367   $ 337 $ (107,248) $ 1,150,198 $ (1,459) $ (87,155)   $ (1,306)